GW Pharmaceuticals PLC- ADR (GWPH) is near the bottom in its industry group according to InvestorsObserver. GWPH gets an overall rating of 38. That means it scores higher than 38 percent of stocks. GW Pharmaceuticals PLC- ADR gets a 21 rank in the Drug Manufacturers - General industry. Drug Manufacturers - General is number 14 out of 148 industries.
Click Here to get the full Stock Score Report on GW Pharmaceuticals PLC- ADR (GWPH) Stock.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 38 means the stock is more attractive than 38 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With GW Pharmaceuticals PLC- ADR Stock Today?
GW Pharmaceuticals PLC- ADR (GWPH) stock has risen 0.31% while the S&P 500 is down -0.19% as of 12:18 PM on Thursday, Nov 21. GWPH is higher by $0.31 from the previous closing price of $99.21 on volume of 753,726 shares. Over the past year the S&P 500 is up 17.08% while GWPH is down -20.68%. GWPH lost -$1.89 per share the over the last 12 months.
To see the top 5 stocks in Drug Manufacturers - General click here.
